CURA logo

Curaleaf Holdings Stock Price

Symbol: TSX:CURAMarket Cap: CA$1.0bCategory: Pharmaceuticals & Biotech

CURA Share Price Performance

CURA Community Fair Values

Recent CURA News & Updates

No updates

Curaleaf Holdings, Inc. Key Details

US$1.3b

Revenue

US$680.4m

Cost of Revenue

US$633.5m

Gross Profit

US$886.0m

Other Expenses

-US$252.4m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 06, 2025
Earnings per share (EPS)
-0.33
Gross Margin
48.22%
Net Profit Margin
-19.21%
Debt/Equity Ratio
80.6%

Curaleaf Holdings, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About CURA

Founded
n/a
Employees
5519
CEO
Boris Jordan
WebsiteView website
www.curaleaf.com

Curaleaf Holdings, Inc. produces and distributes cannabis products in the United States and internationally. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of hemp-derived THC products through wholesale channels. The company is headquartered in Stamford, Connecticut.

U.S. Market Performance

  • 7 Days: 0.8%
  • 3 Months: 19.7%
  • 1 Year: 13.7%
  • Year to Date: 7.0%
The market has been flat in the last week, however the Energy sector is down 3.8%. More promisingly, the market is up 14% over the past year. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›
The tide is turning for UK & European markets. Index ETFs won’t cut it since sector spreads are massive. Picking the right companies matters now more than ever.
Continue reading